SCHEMBL2374148

SCHEMBL2374148

c1cc(N2CCC(N3CCOCC3)CC2)nc(Nc2ccc3[nH]ccc3c2)n1

nearest known ligand 0.56

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.56
EGFR P00533 7/20 0.51
SYK P43405 5/20 0.51
CCNT1 O60563 1/20 0.45
CDK9 P50750 1/20 0.45
EPHB4 P54760 1/20 0.44
SMG1 Q96Q15 2/20 0.43
PARP1 P09874 1/20 0.42
JAK1 P23458 1/20 0.42
JAK3 P52333 1/20 0.42
FLT1 P17948 1/20 0.42
ULK1 O75385 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2376050 0.82 CYP3A4 (0.46) JAK2SYKSMG1PARP1JAK1
SCHEMBL31681826 0.82 CYP3A4 (0.46) JAK2SYKSMG1PARP1JAK1
SCHEMBL2376107 0.80 SMG1 (0.56) JAK2SMG1PARP1JAK1JAK3
SCHEMBL2375403 0.78 PLK4 (0.55) JAK2EPHB4SMG1PARP1JAK1
SCHEMBL31681845 0.76 SMG1 (0.51) EGFRSYKSMG1FLT1
SCHEMBL2375211 0.76 SMG1 (0.51) EGFRSYKSMG1FLT1
SCHEMBL2375410 0.76 ZAP70 (0.61) EGFR
SCHEMBL12231947 0.74 ZAP70 (0.49) JAK2EGFRSYKEPHB4SMG1
SCHEMBL30839088 0.74 JAK2 (0.64) JAK2SYKPARP1JAK1JAK3
SCHEMBL2374619 0.73 EGFR (0.53) JAK2EGFRSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12410397-B2 Methods of enhancing cell survival of stem cells THE SCRIPPS RESEARCH INSTITUTE (US) 2025-09-09 US disclosed
EP-4585589-A2 STEM CELL CULTURES The Scripps Research Institute (US) 2025-07-16 EP disclosed
EP-4296270-B1 A COMPOSITION COMPRISING STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2025-06-18 EP disclosed
EP-4296270-A2 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2023-12-27 EP disclosed
EP-3936508-B1 A COMPOSITION COMPRISING STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2023-12-06 EP disclosed
EP-3936508-A1 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2022-01-12 EP disclosed
EP-3936508-A1 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2022-01-12 EP disclosed
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS THE SCRIPPS RESEARCH INSTITUTE 2021-12-30 US disclosed
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS THE SCRIPPS RESEARCH INSTITUTE 2021-12-30 US disclosed
EP-3623374-B1 STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2021-09-08 EP disclosed
US-20140273214-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2014-09-18 US disclosed
EP-2370445-B1 STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2014-07-23 EP disclosed
EP-2370445-B1 STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2014-07-23 EP disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
WO-2010065721-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140273214-A1 STEM CELL CULTURES NES, CD44, MCL1 JAK2 3276/4885EGFR 2191/4885SYK 4836/4885
US-20110294761-A1 STEM CELL CULTURES NES, CD44, MCL1 JAK2 3276/4885EGFR 2191/4885SYK 4836/4885
US-12410397-B2 Methods of enhancing cell survival of stem cells MCL1, BCL2, BCLAF1 JAK2 3958/4885EGFR 3390/4885SYK 4827/4885
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS MCL1, BCL2, BCLAF1 JAK2 3958/4885EGFR 3390/4885SYK 4827/4885
US-20110224233-A1 STEM CELL CULTURES NES, CD44, MCL1 JAK2 3276/4885EGFR 2191/4885SYK 4836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.